Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

DBV Technologies S.A. (DBVT) Cash Flow Statement

DBV Technologies S.A. (DBVT) generated -$169.3M of operating cash flow over the twelve months to 2026-06-30, spent $1.3M on capital expenditure and had free cash flow of -$170.6M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

DBVTDBV Technologies S.A.Follow DBVT — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
577.3M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
28 Oct, in 4 days
LineFY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-165.6-108.2-55.7-79.7-104.5-121.2-169.3
Capital expenditure2.80.90.80.72.30.5-1.3
Free cash flow-168.4-109.2-56.4-80.3-106.8-121.7-170.6
Stock-based compensation-1.13.15.06.04.65.4—

USD millions · SEC XBRL

DBV Technologies S.A. — questions

What is DBV Technologies S.A.'s operating cash flow?
-$169.3M over the twelve months to 2026-06-30.
How much does DBV Technologies S.A. spend on capital expenditure?
$1.3M over the twelve months to 2026-06-30.
What is DBV Technologies S.A.'s free cash flow?
-$170.6M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from DBV Technologies S.A.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.